Radio and PodcastRadio and PodcastLive Radio & Podcasts
Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential of TROP2-Targeted Antibody-Drug Conjugates in Earlier Lines and Disease-Stage Settings artwork
Science & Medicine

Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential of TROP2-Targeted Antibody-Drug Conjugates in Earlier Lines and Disease-Stage Settings

PeerVoice Clinical Pharmacology Video by PeerVoice, 1140 Avenue of the Americas, 15th Floor, New York, NY 10036

Jan 7, 202600:21:47Science & Medicine

Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential of TROP2-Targeted Antibody-Drug Conjugates in Earlier Lines and Disea...

About This Episode

Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential of TROP2-Targeted Antibody-Drug Conjugates in Earlier Lines and Disease-Stage Settings is...

Podcast

This episode belongs to PeerVoice Clinical Pharmacology Video.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jan 7, 2026, 00:21:47 long, audio available.

Related Episodes

Continue listening to more episodes from PeerVoice Clinical Pharmacology Video.